↓ Skip to main content

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy

Overview of attention for article published in BioDrugs, July 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 756)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
85 news outlets
blogs
8 blogs
policy
1 policy source
twitter
16 X users
patent
75 patents
wikipedia
7 Wikipedia pages
googleplus
1 Google+ user

Citations

dimensions_citation
811 Dimensions

Readers on

mendeley
2605 Mendeley
Title
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Published in
BioDrugs, July 2017
DOI 10.1007/s40259-017-0234-5
Pubmed ID
Authors

Michael F. Naso, Brian Tomkowicz, William L. Perry, William R. Strohl

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 2,605 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 2605 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 416 16%
Student > Ph. D. Student 362 14%
Student > Master 305 12%
Researcher 292 11%
Student > Doctoral Student 94 4%
Other 268 10%
Unknown 868 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 704 27%
Agricultural and Biological Sciences 209 8%
Neuroscience 156 6%
Medicine and Dentistry 124 5%
Pharmacology, Toxicology and Pharmaceutical Science 119 5%
Other 379 15%
Unknown 914 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 712. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2024.
All research outputs
#29,246
of 25,734,859 outputs
Outputs from BioDrugs
#1
of 756 outputs
Outputs of similar age
#559
of 327,779 outputs
Outputs of similar age from BioDrugs
#1
of 9 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 756 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,779 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them